← Back to headlines
H.C. Wainwright Raises Price Target on Lexicon Pharmaceuticals to $6
H.C. Wainwright has increased its price target for Lexicon Pharmaceuticals, Inc. (LXRX) from $4 to $6, maintaining a 'Buy' rating.
12 Mar, 07:38 — 12 Mar, 07:38
Sources
Showing 1 of 1 sources
